| Predicted NM | Predicted M | P value |
---|---|---|---|
Patient cohort (n = 198) | n = 137 | n = 61 | Â |
Gender(male/female) | 121/16 | 53/8 | 0.9601 |
Age(yr, mean ± SD) | 49.99 ± 11.22 | 50.15 ± 9.54 | 0.8235 |
Number of nodule(1/2/3/4) | 117/18/2 | 55/4/1/1 | 0.2603 |
Tumor capsule(complete/none) | 53/84 | 24/37 | 0.9441 |
Cirrhosis(no/yes) | 8/129 | 5/56 | 0.7584 |
AFP(log2-transformed, mean ± SD) | 6.79 ± 3.96 | 8.08 ± 4.56 | 0.0395 |
TB(μmol/L, median(25-75%)) | 15.4(12.1-20.2) | 17.4(11.4-22.1) | 0.2954 |
ALT(μ/L, median(25-75%)) | 43(31-61) | 49(32-66) | 0.3929 |
OKUDA stage(0/1) | 119/18 | 49/12 | 0.3325 |
CLIP stage(0/1/2/3/4) | 64/49/22/1/1 | 28/15/12/4/2 | 0.0509 |
BCLC stage(0/A/B/C) | 15/103/14/5 | 7/35/7/12 | 0.0022 |
TNM stage(I/II/III) | 65/57/15 | 23/23/15 | 0.0441 |
Child-Pugh class(A/B) | 132/5 | 57/4 | 0.5910 |